| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2932 |
| Trial ID | NCT05239676 |
| Disease | Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | AUTO-CAR-T-001 |
| Co-treatment | Autologous hematopoietic stem cell transplantation |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Autologous Hematopoietic Stem Cell Transplantation Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Malignant Lymphoma |
| Year | 2022 |
| Country | China |
| Company sponsor | Zhejiang University |
| Other ID(s) | AUTO-CART-001 |
| Cohort 1 | |||||||||
|
|||||||||